Mar 11 |
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
|
Feb 15 |
Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock
|
Feb 14 |
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
|
Feb 6 |
Nasdaq Down 50 Points; Willis Towers Watson Posts Upbeat Profit
|
Feb 6 |
BioRestorative Therapies tumbles after private placement
|
Feb 6 |
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
|
Feb 5 |
BioRestorative stock climbs 8% amid data presentation for disc therapy
|
Feb 5 |
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
|
Feb 1 |
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
|
Dec 12 |
BioRestorative Therapies receives notice of allowance by US Patent and Trademark Office for patent application related to its obesity program
|